Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.
about
Hospitalization in older patients due to adverse drug reactions -the need for a prediction toolSystemic review on drug related hospital admissions - A pubmed based searchWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi processPrediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score)Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for DeprescribingDevelopmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study.Concordance and predictive value of two adverse drug event data sets.Variation in high-priority drug-drug interaction alerts across institutions and electronic health recordsAdverse drug events-Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database.Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.Assessing potentially inappropriate prescribing (PIP) and predicting patient outcomes in Ontario's older population: a population-based cohort study applying subsets of the STOPP/START and Beers' criteria in large health administrative databases.Prevalence of Drug-Related Emergency Department Visits at a Teaching Hospital in Malaysia.Applying STOPP Guidelines in Primary Care Through Electronic Medical Record Decision Support: Randomized Control Trial Highlighting the Importance of Data Quality.Developing and testing an electronic medication administration monitoring device for community dwelling seniors: a feasibility studyThe economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.Effectiveness of a multidisciplinary home-based medication review program in reducing healthcare utilization among older adult Singaporeans.The efficacy of fall-risk-increasing drug (FRID) withdrawal for the prevention of falls and fall-related complications: protocol for a systematic review and meta-analysisHospital admissions due to adverse drug reactions in the elderly. A meta-analysis.Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.Survey of patients' experiences and their certainty of suspected adverse drug reactions.5-Fluorouracil toxicity and dihydropyrimidine dehydrogenase enzyme: implications for practice.Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006.Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia.Use of a trigger tool to detect adverse drug reactions in an emergency department.Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients.Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions.GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647).Derivation and validation of a multivariable model to predict when primary care physicians prescribe antidepressants for indications other than depression.
P2860
Q26748526-B31105AB-305D-4943-ADC9-13BCCD0E01ADQ27027353-C306B173-139D-4EB5-8782-78F763728A37Q28545785-0BF9CC31-D2BF-4B5B-BECD-D9AD3C802F70Q28553063-B08D551E-D37C-4047-B100-CA12FEF63A34Q28553495-ABB33248-24C6-4997-8F3C-39471200581EQ30654648-168C662B-B870-4260-A17A-EDCE6C76BC41Q30844334-AB96C4FA-C2BB-456C-833A-2E26766E273DQ33564868-6F91B7ED-975D-4F07-8C2C-0C1C20412C27Q33757595-F4A3275E-AE84-489A-96A2-8F8E4E4DD950Q34657198-687803B2-D9F6-4C35-B34C-BCFC1F5089ACQ35153278-8B062460-09C1-48DA-B95E-70104167FED6Q36329333-3B860B68-BAE5-435F-A538-D357AD6772B2Q36360202-3787E7D2-6013-46DC-A6C2-88A07DBF13EBQ36406859-A3B578D1-6E2A-4445-9919-6045F6269ACFQ37618710-FEC483B3-0C06-482A-A9F7-14C627FE9CC6Q38085227-90F64240-94CD-4E22-97CC-0565A167F8DCQ38095530-3BA29F62-3F7C-4C3F-8079-3FABD1C7A377Q38129733-E6B96EEB-5AA0-4D6A-8E4F-F9F3CC8C68B7Q38627473-FF2DB859-46BB-4840-BEC4-6ECC35BFCD61Q38704239-BCE55B0E-5F65-4F7E-9776-1C4A52CFB2C7Q38951494-53F9CE25-CC20-472E-B1B1-B5775A4850CBQ39157386-BAED59D9-C449-400D-A4D8-4D27FC1B644AQ40124433-4E1B1A06-1786-4920-856A-064E8E5A4D14Q40130181-5272E55F-C1FE-4F19-95C2-AF79EB06CA87Q41598140-A1C7A2EF-E4DA-4333-83E3-375AABD9B989Q42045678-BE380583-4677-4448-B7CC-92AF112511C6Q43733539-466FBC14-B18A-4060-A979-384BDD7A32FDQ44975072-9364F402-1508-40C3-8BFB-7209BF2B25B6Q45902688-97CB121D-28CE-498A-970D-484EEF067F62Q47101791-54210DB6-5981-4E1B-A50F-8BE4BC094522Q47447271-510A7CD6-D876-4D2C-A29A-325E5E01DB51Q51150147-C61EFD1E-9FEF-4D13-ADCF-6A3F4B182A26Q53231509-3EFAFDFA-E0F9-4E81-80B3-823F286DADB0Q55310487-3FC36EAB-CB29-42EF-B495-D7A514E4074FQ55313541-43D45346-95B9-4D56-BB78-84F81ACC2B89
P2860
Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incidence and economic burden ...... tments: a retrospective study.
@en
Incidence and economic burden ...... tments: a retrospective study.
@nl
type
label
Incidence and economic burden ...... tments: a retrospective study.
@en
Incidence and economic burden ...... tments: a retrospective study.
@nl
prefLabel
Incidence and economic burden ...... tments: a retrospective study.
@en
Incidence and economic burden ...... tments: a retrospective study.
@nl
P2093
P2860
P356
P1433
P1476
Incidence and economic burden ...... tments: a retrospective study.
@en
P2093
Chaim M Bell
Walter P Wodchis
P2860
P2888
P304
P356
10.1007/BF03261973
P577
2012-09-01T00:00:00Z